February 2008
·
11 Reads
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
February 2008
·
11 Reads
March 2007
·
9 Reads
Laboratory Investigation
March 2007
·
7 Reads
Laboratory Investigation
March 2007
·
2 Reads
Modern Pathology
March 2007
·
8 Reads
Modern Pathology
January 2006
·
3 Reads
International Journal of Radiation Oncology*Biology*Physics
January 2006
·
5 Reads
·
6 Citations
Laboratory Investigation
January 2006
·
4 Reads
Modern Pathology
January 2005
·
5 Reads
Modern Pathology
January 2005
·
1 Read
Modern Pathology
... Insulin-degrading enzyme (IDE) is a ubiquitously expressed zinc metalloendopeptidase [1]. It was initially identified as an insulin-clearing enzyme (the role for which it was named) [2]. ...
February 1993
Endocrinology
... Other differential diagnostic considerations may be lymphoma, chronic osteomyelitis, osteoblastoma, and osteoid osteoma. Complications that occur predominantly in the pelvic region are osteoarthritis, fractures (proximal femur) and Paget sarcoma (usually osteosarcoma in iliac bone and proximal femur)789. ...
January 2006
Laboratory Investigation
... ej., TNFα, INFγ, etc.). Empleando técnicas de biología molecular, surgió TPB, la versión humanizada de OKT3, que mantie-ne la especificidad por el CD3, pero con cambios de aminoácidos (Ala en las posiciones 234 y 235) 27 . ...
March 1992
Diabetes
... Après avoir été démontré compétiteur, CTLA-4 a été démontré inhibiteur de la réponse immunitaire (Lenschow et al., 1992(Lenschow et al., , 1993Walunas et al., 1994). Ces propos servent ainsi la pertinence d'étude et de considération des molécules CD80 et CD86, au vu de leur implication dans la régulation de la réponse immunitaire. ...
January 1992
Science
... E-cadherin overexpression is a positive prognostic factor in the clinical course of endometrioid endometrial cancer [117]. High E-cadherin expression is associated with reduced mortality, disease progression, and rate of disease recurrence [118]. ...
October 2003
International Journal of Radiation Oncology*Biology*Physics
... Current-day treatment of ABC advocated by many is curettage with or without bone graft. To augment this procedure, high-speed burr has been described by one study done by Gibbs et al., [20] where 40 patients showed nearly 90% control rate after a median 7.2-year follow-up, following curettage, without the use of phenol, liquid nitrogen, or any other adjuvant. Burr works by mechanical disruption of the lesion to the level of the bone circumscribing the lesion. ...
December 1999
The Journal of Bone and Joint Surgery
... There is also a model of spontaneous EAN in non-obese diabetic (NOD) mice that are deficient in the co-stimulatory B7-2 molecule (154). In this model there is inflammation and demyelination of peripheral nerves, with a chronic course. ...
September 2001
... Based on this approach, a new wave of immunotherapieshas surfaced. One of the pioneering ones includes the generation of a chimeric CTLA-4-Ig protein, which is responsible for blocking co-stimulation through CD28 (Lenschow et al. 1992). Potent activation of TCR signalling cascade is highly dependent on the interaction of CD28 on T cells and its ligands, CD80 or CD86 on APCs. ...
Reference:
Immunomodulation in Autoimmune Disorders
September 1992
Science
... Both are ligands for programmed death-1 (PD-1), which is expressed on activated T and B cells [4][5][6]. PD-L1 has been described to be inducibly expressed in a variety of organs [3,[7][8][9][10][11][12][13]]. An overwhelming number of studies supported the role of PD-L1 as a negative regulator of T cell responses and suggest that PD-L1 promotes peripheral tolerance [14]. ...
November 1992
... A recent study by Brouwers et al. demonstrated a novel molecular mechanism of one of the most extensively studied proprotein convertases (PCs), furin, in regulating glucose levels in β-cells [29]. PCs are proteolytic enzymes that are ubiquitously involved in many biological processes and play crucial roles in regulating metabolic diseases [30,31]. In their study, they showed that the absence of furin-mediated mTORC1 activation led to β-cell dysfunction (Figure 2 bottom panel) [29]. ...
October 1992
Proceedings of the National Academy of Sciences